Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Theravance BiopharmaIGM BiosciencesNabriva TherapeuticsMadrigal PharmaceuticalsZEALAND PHARMA/S
SymbolNASDAQ:TBPHNASDAQ:IGMSNASDAQ:NBRVNASDAQ:MDGLNASDAQ:ZEAL
Price Information
Current Price$23.06$52.99$0.59$70.11$31.46
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$36.00$35.00$5.14$159.17$40.33
% Upside from Price Target56.11% upside-33.95% downside773.00% upside127.02% upside28.21% upside
Trade Information
Market Cap$1.33 billion$1.42 billion$582.03 million$1.05 billion$1.11 billion
Beta1.73N/A1.960.951.85
Average Volume463,013142,9061,505,835177,98211,192
Sales & Book Value
Annual Revenue$73.41 millionN/A$9.48 millionN/A$6.20 million
Price / Sales19.79N/A58.80N/A182.92
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($3.94) per share$7.87 per share$0.04 per share$27.00 per share$5.85 per share
Price / Book-5.85N/A14.73N/A5.38
Profitability
Net Income$-236,460,000.00$-43,130,000.00$-82,760,000.00$-83,950,000.00$-85,670,000.00
EPS($4.25)($4.80)($1.12)($5.45)($2.54)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-322.08%N/A-872.95%N/AN/A
Return on Equity (ROE)N/AN/A-179.92%-18.84%-48.45%
Return on Assets (ROA)-50.37%N/A-89.03%-18.17%-38.66%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.05%0.84%N/A0.06%
Current Ratio3.03%26.04%5.48%17.52%7.31%
Quick Ratio3.03%26.04%5.44%17.52%7.31%
Ownership Information
Institutional Ownership Percentage71.64%40.89%3.25%67.83%7.40%
Insider Ownership Percentage6.60%N/A3.32%47.69%N/A
Miscellaneous
Employees36340N/A17149
Shares Outstanding63.00 million30.54 million946.23 million15.43 million36.05 million
Next Earnings Date5/5/2020 (Estimated)6/25/2020 (Estimated)5/8/2020 (Estimated)5/13/2020 (Estimated)5/21/2020 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel